UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000032719
Receipt number R000037310
Scientific Title Effect of dietary trans fatty acid level on serum lipid concentration
Date of disclosure of the study information 2018/05/31
Last modified on 2022/04/28 18:12:25

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of dietary trans fatty acid level on serum lipid concentration

Acronym

Effect of 2%E trans fatty acids on serum lipid concentration

Scientific Title

Effect of dietary trans fatty acid level on serum lipid concentration

Scientific Title:Acronym

Effect of 2%E trans fatty acids on serum lipid concentration

Region

Japan


Condition

Condition

Life-style related disease

Classification by specialty

Medicine in general Adult

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

To investigate effect of 2%E trans fatty acids on blood lipid and glucose metabolism in healthy men and women

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Serum lipid levels, after 4 weeks

Key secondary outcomes

Diabetes markers, Cardio Ankle Vascular Index, Blood pressure


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Control group
Period: 4 weeks
Intervention: Supplement of less than 0.1%E trans fatty acids in addition to regular diet every day

Interventions/Control_2

Trans fatty acid group
Period: 4 weeks
Intervention: Supplement of 2%E trans fatty acids in addition to regular diet every day

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

69 years-old >=

Gender

Female

Key inclusion criteria

General healthy women

Key exclusion criteria

Patients under treatment of dyslipidemia and diabetes

Target sample size

70


Research contact person

Name of lead principal investigator

1st name Hiroyuki
Middle name
Last name Takeuchi

Organization

Toyama College

Division name

Food and nutrition

Zip code

930-0193

Address

444 mizuguchi, gankai-zi, Toyama-shi, Toyama

TEL

076-436-5168

Email

wistar1111@gmail.com


Public contact

Name of contact person

1st name Hiroyuki
Middle name
Last name Takeuchi

Organization

Toyama College

Division name

Food and nutrition

Zip code

9310193

Address

444 mizuguchi, gankai-zi, Toyama-shi, Toyama

TEL

076-436-5168

Homepage URL


Email

wistar1111@gmail.com


Sponsor or person

Institute

Toyama College

Institute

Department

Personal name



Funding Source

Organization

Toyama College

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Toyama College

Address

444 Mizugchi Gankaiji Toyama

Tel

076-436-5176

Email

kyoumu@toyama-c.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 05 Month 31 Day


Related information

URL releasing protocol

https://endai.umin.ac.jp/cgi-open-bin/ojac/search/ojac_search.cgi?cond=%27A00093-00031-10007%27&parm

Publication of results

Published


Result

URL related to results and publications

https://endai.umin.ac.jp/cgi-open-bin/ojac/search/ojac_search.cgi?cond=%27A00093-00030-10008%27&parm

Number of participants that the trial has enrolled

39

Results

There were no significant differences in total cholesterol, LDL-cholesterol, HDL-cholesterol, blood glucose levels, or HbA1c between the control group and the trans acid group. Compared with the control group, the trans acid group showed significantly higher values in triglyceride and insulin. The amount of trans acid in erythrocytes of the trans acid group was significantly higher than that of the control group.

Results date posted

2022 Year 04 Month 28 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

Healthy adult women in their 20s and 60s

Participant flow

Forty-four people wanted to participate, but two people declined on the way due to personal reasons. A blood test revealed that three people needed treatment.

Adverse events

none

Outcome measures

LDL-cholesterol, HDL-cholesterol, blood glucose, HbA1c, triglycerides, insulin

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 03 Month 01 Day

Date of IRB

2018 Year 03 Month 31 Day

Anticipated trial start date

2018 Year 06 Month 01 Day

Last follow-up date

2018 Year 11 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 05 Month 25 Day

Last modified on

2022 Year 04 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000037310


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name